Back to top
more

QuidelOrtho (QDEL)

(Delayed Data from NSDQ)

$36.18 USD

36.18
1,152,623

-2.78 (-7.14%)

Updated Nov 15, 2024 04:00 PM ET

After-Market: $36.21 +0.03 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 48% (129 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Swayta Shah headshot

5 Stocks With Solid Sales Growth to Buy Amid Market Volatility

by Swayta Shah

Steady sales growth is vital to gauge a company's health and ability to sustain its business. Let's check out Sanderson Farms (SAFM), Quidel (QDEL), Crown Holdings (CCK), Everest Re (RE) and Eversource Energy (ES) that are witnessing top-line growth.

Should Value Investors Buy These Medical Stocks?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cooper Companies (COO) Q1 Earnings & Revenues Beat Estimates

by Zacks Equity Research

Cooper Companies' (COO) fiscal first-quarter earnings reflect solid segmental performance.

Quidel (QDEL) Rallies 17.4% Since Posting Q4 Earnings Beat

by Zacks Equity Research

Quidel (QDEL) stock rallies on better-than-expected fourth-quarter performance and strong diagnostics portfolio.

Patterson Companies (PDCO) Q3 Earnings Beat, Revenues Lag

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter 2022 results benefit from strength in the Dental and Animal Health segments.

Cooper Companies (COO) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Cooper Companies' (COO) fiscal first-quarter results are likely to reflect segmental strength.

Benjamin Rains headshot

Find Strong Stocks to Buy in March with New Analyst Coverage

by Benjamin Rains

Investors who decide to stay on the hunt for stocks might want to utilize our new analyst coverage screen to help find potential winners for March and beyond...

What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Animal Health segment.

DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Miss Estimates

by Zacks Equity Research

Despite a year-over-year decline in both earnings and revenues, DENTSPLY SIRONA's (XRAY) fourth-quarter results benefit from Technologies & Equipment business.

Inari Medical (NARI) Gains 12.5% Despite In-Line Q4 Earnings

by Zacks Equity Research

Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all of its growth drivers.

Are These Medical Stocks Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's How Much You'd Have If You Invested $1000 in Quidel a Decade Ago

by Zacks Equity Research

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Cerner (CERN) Q4 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

Cerner's (CERN) fourth-quarter results benefit from gains across four of its business units.

LHC Group (LHCG) Q4 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research

Despite the weak bottom-line performance, LHC Group's (LHCG) fourth-quarter results benefit from organic growth in home health admissions.

Wall Street Analysts Believe Quidel (QDEL) Could Rally 47%: Here's is How to Trade

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 46.8% in Quidel (QDEL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Quidel (QDEL) Q4 Earnings Top Estimates, Margins Decline

by Zacks Equity Research

Despite robust revenues from COVID-19 products, Quidel (QDEL) records an overall soft Q4 performance.

Quidel (QDEL) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Quidel (QDEL) delivered earnings and revenue surprises of 49.08% and 0.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Quidel's (QDEL) fourth-quarter results are likely to reflect continued strength across its SARS-related products.

Analysts Estimate Quidel (QDEL) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Neptune Wellness (NEPT) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Neptune Wellness (NEPT) delivered earnings and revenue surprises of -50% and 7.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Quidel (QDEL) closed at $95.02 in the latest trading session, marking a -1.43% move from the prior day.

Here's Why You Should Add Quidel (QDEL) Stock To Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.

Quidel (QDEL) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Quidel (QDEL) closed at $103.36, marking a +1.59% move from the previous day.

Nitish Marwah headshot

4 Stocks With High Net Income Ratio to Scoop Up

by Nitish Marwah

FLGT, AAWW, BBW, and QDEL passed the screen for the stocks with a high net income ratio.